Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2012 Aug 1.

Published in final edited form as: Psychoneuroendocrinology. 2011 Jan 13;36(7):945–954. doi: 10.1016/j.psyneuen.2010.11.010

PANAS-NOW negative affect (NA; Figure 3A) and positive affect (PA; Figure 3B) scores at each of the seven measurement points throughout the study sessions, by drug and session (S1 = Session 1; S2 = Session 2). Error bars represent SEM. White bars indicate placement of intravenous lines; black bars indicate infusion. The Picture Task occurred during the latter half of the infusion (black bar). “Cortisol-first” group, N=24; “placebo-first” group, N=23. Figure 3C shows PANAS NA scores at PANAS administration #4, immediately after the Picture Task, by drug and session. Error bars represent SEM. Left, participants who received cortisol in Session 1 and placebo in Session 2; right, participants who received placebo in Session 1 and cortisol in Session 2. * indicates significant difference in post-hoc test, p < 0.05; ** indicates p < 0.01. There is no significant difference between Session 1 and 2 NA in the group who received placebo first (right two bars).

PANAS-NOW negative affect (NA; Figure 3A) and positive affect (PA; Figure 3B) scores at each of the seven measurement points throughout the study sessions, by drug and session (S1 = Session 1; S2 = Session 2). Error bars represent SEM. White bars indicate placement of intravenous lines; black bars indicate infusion. The Picture Task occurred during the latter half of the infusion (black bar). “Cortisol-first” group, N=24; “placebo-first” group, N=23. Figure 3C shows PANAS NA scores at PANAS administration #4, immediately after the Picture Task, by drug and session. Error bars represent SEM. Left, participants who received cortisol in Session 1 and placebo in Session 2; right, participants who received placebo in Session 1 and cortisol in Session 2. * indicates significant difference in post-hoc test, p < 0.05; ** indicates p < 0.01. There is no significant difference between Session 1 and 2 NA in the group who received placebo first (right two bars).